William Stohl - Concepedia

Author

William Stohl

Also Known As

Handa, Paul, Kuhnz, W., R. F. van Vollenhoven, Stohl, W, Stohl, William, W Stohl, W. STOHL, W. Stohl, WILLIAM STOHL, William Stohl

205

Publications

13.5K

Citations

H-Index

Concepts

All Affiliations

University of Southern California Human Genome Sciences (United States)University of Pennsylvania Albert Einstein College of Medicine Southern California University for Professional Studies

About

William Stohl is an author at University of Southern California specializing in medicine, autoimmunity, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	21	36	2K
2	Cell Biology	17	20	776
3	Allergy	10	10	222
4	Social Sciences	2	2	69
5	Cellular Physiology	1	1	17

William Stohl

105

Publications

12.3K

Citations

H-Index

Page 1

	Year	Citations
A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus Richard Furie, Michelle Petri, Omid Zamani, Arthritis & Rheumatism	2011	1.6K
Elevated serum B lymphocyte stimulator levels in patients with systemic immune-based rheumatic diseases Gurtej S. Cheema, Viktor Roschke, David M. Hilbert, Arthritis & Rheumatism	2001	789
A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study of belimumab in patients with active systemic lupus erythematosus Daniel J. Wallace, William Stohl, Richard Furie, Arthritis Care & Research	2009	586
B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: Longitudinal observations William Stohl, Samy Metyas, Soon‐Min Tan, Arthritis & Rheumatism	2003	487
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial Roy Fleischmann, Eduardo Mysler, Stephen Hall, The Lancet Rheumatoid DisorderRheumatologyTofacitinib MonotherapyMedicineRheumatic Diseases	2017	479
Novel evidence‐based systemic lupus erythematosus responder index Richard Furie, Michelle Petri, Daniel J. Wallace, Arthritis Care & Research	2009	468
Association of plasma B lymphocyte stimulator levels and disease activity in systemic lupus erythematosus Michelle Petri, William Stohl, Winn Chatham, Arthritis & Rheumatism	2008	410
Belimumab reduces autoantibodies, normalizes low complement levels, and reduces select B cell populations in patients with systemic lupus erythematosus William Stohl, Falk Hiepe, Kevin Latinis, Arthritis & Rheumatism	2012	408
Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty‐Two–Week Randomized, Double‐Blind, Placebo‐Controlled Study William Stohl, Andreas Schwarting, Masato Okada, Arthritis & Rheumatology	2017	391
Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial Paul P. Tak, William F. C. Rigby, Andrea Rubbert‐Roth, Annals of the Rheumatic Diseases	2010	300

Page 1